AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2014
Aug 6, 2014
34975_dirs_2014-08-06_aa131d01-02f3-4208-86ba-4541c45882dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-08-05
Reporting Person: HARTE NEAL J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-05 | Common Stock | M | 26352 | $2.15 | Acquired | 71010 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-05 | Stock option (right to buy) | $2.15 | M | 26352 | Disposed | 2015-05-26 | Common stock, par value $0.01 per share (26352) | Direct |
Footnotes
F1: Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 47,922 shares of common stock held by the Reporting Person.
F2: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.
F3: The options vested in three equal installments on January 1, 2006, 2007 and 2008.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17